FiercePharma2h
BMS, Merck, Amgen and more must pursue M&A to offset looming patent lapses: Leerink
As a wave of patent expirations encroaches upon many of the world’s top drugmakers, companies will need to be diligent in ...
US FDA declines full approval for Intercept's liver disease drug
The U.S. Food and Drug Administration on Tuesday declined full approval for Intercept Pharmaceuticals' liver disease drug, ...
Los Angeles Times5h
Working to End the HIV Epidemic Through Innovation, Equity, Collaboration & Choice
Gilead is committed to designing trials to help understand how HIV treatment and prevention impact populations that have been ...